Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.4 DKK | +1.02% | +0.37% | -15.10% |
Mar. 13 | Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults | MT |
Mar. 13 | Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.10% | 1.66B | |
+25.83% | 661B | |
+26.47% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.60% | 231B | |
+5.37% | 200B | |
-8.92% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BAVA Stock
- News Bavarian Nordic A/S
- Bavarian Nordic Receives EUR11 Million Smallpox Vaccine Contract